100 related articles for article (PubMed ID: 3322707)
1. [Effect of sheng mai decoction on left ventricular function in patients with coronary heart disease. A randomized, double-blind, placebo-controlled, cross-over trial].
Fang J; Jiang J; Luo DC
Zhonghua Nei Ke Za Zhi; 1987 Jul; 26(7):403-6, 445. PubMed ID: 3322707
[No Abstract] [Full Text] [Related]
2. [Effect of sheng-mai decoction on left ventricular performance and exercise tolerance in patients with dilated cardiomyopathy].
Jiang J; Fang J; Luo DC
Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):65-7, 125. PubMed ID: 3058445
[No Abstract] [Full Text] [Related]
3. Effect of sheng mai san on left ventricular performance in coronary heart disease.
Liao JZ; Wu ZM; Kang TP; Shi ZX; Guo LZ; Zhao YR; Wang ZG; Hao QC
J Tradit Chin Med; 1982 Mar; 2(1):57-62. PubMed ID: 6765690
[No Abstract] [Full Text] [Related]
4. [A clinical trial of sheng-mai liquor in the treatment of ischemic heart disease].
Yu Z; Chen KJ; Qian ZH
Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Jun; 15(3):144-7, 190-1. PubMed ID: 2963736
[No Abstract] [Full Text] [Related]
5. [Anti-ischemia effect of enalapril in coronary heart disease. A randomized placebo-controlled double-blind study].
Rietbrock N; Thürmann P; Kirsten R; Schneider W
Dtsch Med Wochenschr; 1988 Feb; 113(8):300-2. PubMed ID: 2830091
[TBL] [Abstract][Full Text] [Related]
6. [Double blind study of the therapeutic effect of cyclovirobuxine D No. 1 on the left ventricular function in coronary heart disease].
Zhonghua Xin Xue Guan Bing Za Zhi; 1983 Jun; 11(2):89-91. PubMed ID: 6628220
[No Abstract] [Full Text] [Related]
7. [A control trial of flavonoids of Hippophae rhamnoides L. in treating ischemic heart disease].
Zhang MS
Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Apr; 15(2):97-9. PubMed ID: 3304921
[No Abstract] [Full Text] [Related]
8. [Clinical study on "sini" decoction on treating stenocardia for coronary heart disease].
Liang Y
Zhong Yao Cai; 2005 Aug; 28(8):737-9. PubMed ID: 16379430
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics of cardiac function and the effect of shengmai injection on qi deficiency and qi-yin deficiency in patients with coronary heart disease].
Chen YQ; Chen KJ
Zhong Xi Yi Jie He Za Zhi; 1988 Sep; 8(9):523-6, 515-6. PubMed ID: 3248344
[No Abstract] [Full Text] [Related]
10. [Effects of sheng mai injection on thoracoabdominal motion].
Wang W; Niu RJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Feb; 13(2):91-3, 69. PubMed ID: 8334346
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive assessment of left ventricular performance in patients with coronary artery disease after chronic diltiazem therapy.
Cinquegrana G; Spinelli L; Ferro G; Cristiano C; Spadafora M; Ferrara M
Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):27-9. PubMed ID: 2744903
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and experimental study of left ventricular diastolic function in heart qi insufficiency syndrome].
Cheng W; Shi ZX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Mar; 13(3):139-43, 131. PubMed ID: 8339029
[TBL] [Abstract][Full Text] [Related]
13. [Mechano- and impedance cardiography parameters in patients with heart failure in administration of a calcium antagonist. The significance of the Heather index].
Linde M; Ohnhaus EE; Kirch W
Z Kardiol; 1989 Mar; 78(3):181-6. PubMed ID: 2652906
[TBL] [Abstract][Full Text] [Related]
14. Experiment study on the effect of Sheng-Mai injection on the contractivity of diaphragm and its mechanism.
Zhao J; Niu R
Chin Med J (Engl); 1995 Feb; 108(2):90-4. PubMed ID: 7774396
[TBL] [Abstract][Full Text] [Related]
15. [Tetrapolar thoracic rheography in assessing the effectiveness of the treatment of cardiac insufficiency].
Bugaĭ LV; Gavrisiuk VK
Vrach Delo; 1979 Jul; (7):76-7. PubMed ID: 382636
[No Abstract] [Full Text] [Related]
16. [Effects of shen mai san on the left ventricular performance in patients with deficiency of heart-vital energy in coronary heart disease].
Wang YZ; Liao JZ
Zhong Xi Yi Jie He Za Zhi; 1985 Apr; 5(4):223-5, 196. PubMed ID: 3158442
[No Abstract] [Full Text] [Related]
17. [The beneficial effects of lipid-lowering therapy with xuezhikang on cardiac events and total mortality in coronary heart disease patients with or without hypertension: a random, double-blinded, placebo controlled clinical trial].
DU BM; Lu ZL; Chen Z; Wu YF
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):890-4. PubMed ID: 17217713
[TBL] [Abstract][Full Text] [Related]
18. [Study on law using Chinese drug of famous old docter of traditional Chinese medicine to coronary heart disease based on association rules].
Wu R; Liu X; Wang J; Zhou XZ
Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(17):1786-8. PubMed ID: 17993003
[TBL] [Abstract][Full Text] [Related]
19. Nifedipine as an adjunct to St. Thomas' Hospital cardioplegia. A double-blind, placebo-controlled, randomized clinical trial.
Flameng W; De Meyere R; Daenen W; Sergeant P; Ngalikpima V; Geboers J; Suy R; Stalpaert G
J Thorac Cardiovasc Surg; 1986 May; 91(5):723-31. PubMed ID: 3517508
[TBL] [Abstract][Full Text] [Related]
20. [China coronary secondary prevention study (CCSPS): outcomes from analysis of coronary heart disease patients with diabetes].
Lu ZL; Du BM; Chen Z; Wu YF; Yu XH; Zhao YC;
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1067-70. PubMed ID: 16563271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
